PharmaShots Weekly Snapshots (May 17 - 21, 2021)
Published: May 21, 2021 | Tags: BeiGene, Tislelizumab, CT, P-III, RATIONALE 309 Study, Recurrent, Metastatic Nasopharyngeal Cancer
Published: May 21, 2021 | Tags: Aurinia, Lupkynis, voclosporin, AURORA 2 Continuation Study, Lupus Nephritis, EULAR 2021
Published: May 21, 2021 | Tags: Takeda, US, FDA, Priority Review, Maribavir, NDA, Post-Transplant CMV Infection
Published: May 21, 2021 | Tags: Astellas, Seagen, Padcev, Two, Studies, Locally Advanced, Metastatic Urothelial Cancer
AstraZeneca's Vaxzevria (AZD1222) Receives Approval for Emergency Use in Japan to Treat COVID-19
Published: May 21, 2021 | Tags: AstraZeneca, Vaxzevria, AZD1222, Approval, Emergency Use, Japan COVID-19
Moderna's COVID-19 Vaccine Receives Approval for Emergency Use in Japan
Published: May 21, 2021 | Tags: Moderna, COVID-19 Vaccine, Approval, Emergency Use, Japan
Lilly Reports Results of Tirzepatide in SURPASS-4 Study for Patients with Type 2 Diabetes
Published: May 20, 2021 | Tags: Lilly, Tirzepatide, SURPASS-4 Study, Type 2 Diabetes
Published: May 20, 2021 | Tags: Janssen, Imbruvica, ibrutinib, Combination Regimen, Chronic Lymphocytic Leukemia, ASCO
Published: May 20, 2021 | Tags: Allogene, ALLO-501, ALLO-501A, P-I, Studies, Relapsed/Refractory Non-Hodgkin Lymphoma
Published: May 20, 2021 | Tags: Janssen, Amivantamab, Lazertinib, P-I, CHRYSALIS Study, EGFR-Mutated NSCLC
Published: May 20, 2021 | Tags: Takeda, Mobocertinib, P-I/II, Study, EGFR Exon20 Insertion+ mNSCLC
Genentech Reports Results of Tecentriq in P-III IMpower010 Study for 1L Treatment of NSCLC
Published: May 20, 2021 | Tags: Genentech, Tecentriq, P-III, IMpower010 Study, NSCLC
Published: May 19, 2021 | Tags: BioXcel, US, FDA, BXCL501, NDA, Agitation, Schizophrenia, Bipolar Disorders I and II
BMS Extends its 2019 Collaboration with Exscientia for AI Driven Drug Discovery
Published: May 19, 2021 | Tags: BMS, Exscientia, AI, Driven Drug Discovery
Published: May 19, 2021 | Tags: Janssen, Mestag, Discover, Novel Fibroblast Targets, Inflammatory Disease
Glaukos Expands its Partnership with Santen for Preserflo MicroShunt
Published: May 19, 2021 | Tags: Glaukos, Partnership, Santen, Preserflo MicroShunt
Sarepta's SRP-9001 Demonstrates Robust Expression and Safety Results in ENDEAVOR Study for DMD
Published: May 19, 2021 | Tags: Sarepta, SRP-9001, Robust Expression, Safety Results, ENDEAVOR Study, DMD
BMS Signs an Exclusive Global License with Agenus for its Anti-TIGIT Bispecific Antibody Program
Published: May 19, 2021 | Tags: BMS, Global License, Agenus, Anti-TIGIT, Bispecific Antibody Program
Published: May 18, 2021 | Tags: BlueRock, Fujifilm, Opsis, Discover, Develop, Cell Therapies, Eye Diseases
Medicago and GSK Report Results of Plant-Derived Vaccine in a P-II Study for COVID-19
Published: May 18, 2021 | Tags: Medicago, GSK, Plant-Derived Vaccine, P-II Study, COVID-19
Roche Receives the US FDA's EUA for cobas SARS-CoV-2 Test to Suspect COVID-19
Published: May 18, 2021 | Tags: Roche, US, FDA, EUA, cobas SARS-CoV-2 Test, COVID-19
Published: May 18, 2021 | Tags: Eli Lilly, Innovent, US, FDA, Sintilimab, Chemotherapy, BLA, Non-Squamous NSCLC
Published: May 18, 2021 | Tags: Regeneron, Sanofi, Dupixent, dupilumab, P-III, VOYAGE Study, Asthma, ATS 2021
Abbott Receives CE Mark for Next-Generation Navitor TAVI System to Treat Aortic Stenosis
Published: May 18, 2021 | Tags: Abbott, CE Mark, Next-Generation, Navitor TAVI System, Aortic Stenosis
Charles River to Acquire Vigene Biosciences for $292.5M
Published: May 17, 2021 | Tags: Charles River, Vigene Biosciences, $292.5M
Published: May 17, 2021 | Tags: Apellis, Empaveli, pegcetacoplan, US, FDA, Approval, Paroxysmal Nocturnal Hemoglobinuria
PerkinElmer to Acquire Immunodiagnostic Systems Holdings for ~$155M
Published: May 17, 2021 | Tags: PerkinElmer, Immunodiagnostic Systems Holdings, ~$155M
Sanofi and GSK Report Results of its COVID-19 Vaccine in a P-II Study Across All Adult Age Groups
Published: May 17, 2021 | Tags: Sanofi, GSK, COVID-19 Vaccine, P-II Study, Adult Age Groups
Published: May 17, 2021 | Tags: BMS, Mavacamten, P-III Study, Obstructive Hypertrophic Cardiomyopathy, ACC 2021
Published: May 17, 2021 | Tags: Biogen, BIIB112, cotoretigene toliparvovec, Primary Endpoint, P-II/III, XIRIUS Study, XLRP
Related Post: PharmaShots Weekly Snapshots (May 10 - 14, 2021)
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com